mergers and acquisitions
Accenture Song acquires ConcentricLife for $245M to boost ad capabilities
Accenture, known for its relentless pursuit of acquisitions, has returned to the deal table once again. The global services company, ...
Avania acquires two medtech CROs, broadens its global services and expertise
Avania, a medtech-focused Contract Research Organization (CRO) headquartered in the Netherlands, has extended its industry expertise through the strategic acquisitions ...
Lilly acquires European biotech Elahere, expands its ADC network and pipeline
Eli Lilly is actively expanding its involvement in the burgeoning field of antibody-drug conjugates (ADCs) in Europe. Following its recent ...
Concentra makes a bid to buy Rain Oncology, a struggling biotech with two cancer drugs
Concentra Biosciences, having weathered a failed acquisition of Atea Pharmaceuticals earlier this year, has now turned its attention to Rain ...
Eversana Intouch acquires Healthware Group to expand its biopharma services portfolio
Eversana Intouch, a prominent biopharma services company in the United States, is taking a significant step by acquiring its long-standing ...
Haemonetics buys OpSens for $253M, a maker of smart TAVR guidewires
Boston-based medical device manufacturer Haemonetics is continuing its focus on expanding its portfolio of interventional cardiology devices with a strategic ...
QHP acquires Applied StemCell to strengthen its cell and gene therapy services for pharma clients
QHP Capital is expanding its portfolio of contract service providers by acquiring Applied StemCell (ASC), a specialized company in cell ...
Kyowa Kirin to buy Orchard Therapeutics for $387M, expanding gene therapy portfolio
Kyowa Kirin has responded to the need to strengthen its late-phase pipeline by finalizing a deal to acquire Orchard Therapeutics ...
EQRx’s ambitious plan to sell cheap drugs falls apart after $4.2B deal
EQRx, a biotech company founded with the ambitious mission of developing affordable medicines, recently found itself embroiled in a complex ...
Novartis Explores Possible Sale of Diagnostic Radiopharmaceutical Agents, Reports Bloomberg
Novartis is reportedly exploring the sale of a portion of its diagnostic radiopharmaceutical agents held under the Advanced Accelerator Applications ...
Cerba HealthCare buys Cirion Biopharma to boost bioanalytical services
French clinical trial lab and diagnostics provider Cerba HealthCare has acquired Canadian CRO Cirion Biopharma in a move aimed at ...
Permira Buys Out CRO Ergomed For £703 Million In Private Deal
Permira, the London-based private equity firm, has made a substantial investment of 703 million pounds sterling (equivalent to $886 million) ...
Singapore’s Hiro Acquires US Oncology CRO To Expand Its Global Footprint
Singapore-based Harvest Integrated Research Organization, known as HiRO, is making a significant move to bolster its global presence through the ...
Abbott Partners With Bigfoot Biomedical To Integrate Diabetes Devices
Abbott has made a significant move by acquiring Bigfoot Biomedical, a diabetes management technology maker. While the financial terms of ...
